Fifth Annual Roseman University Research Symposium at Henderson Campus Gives Public Opportunity to Learn About Local Scientific Research

– Open to the public, the event will showcase 60 local research projects –

HENDERSON, Nev. – March 5, 2019 – Roseman University of Health Sciences will hold its Fifth Annual Research Symposium from 2 to 6:30 p.m. on Wednesday, March 6 at its campus located at 11 Sunset Way, Henderson, Nev., 89014.

The Research Symposium, made possible by a generous donation from our Presenting Sponsors, Zions Bank & Practice Pathways, is open to the public and will showcase 60 research projects by students, residents, research fellows and faculty from Roseman’s Colleges of Pharmacy, Medicine, Dental Medicine and Nursing.

This year’s abstracts cover a wide range of topics in various areas including bench-top science, clinical research, and educational research. These works independently and collectively represent prodigious planning, methodical execution, and deeply insightful findings. With a wide breadth and depth of scientific subject matter, they are steps towards solutions, solutions that advance not only our work and our national and international reputation, but advance the human race. Some of these presentations address a number of diseases including PTSD, HIV/AIDS, diabetes, cancer, depression and fatty liver disease. Other presentations address important health issues such as e-cigarette usage, geriatric health, cannabinoids, opioid prescribing trends and youth prescription abuse. These are in addition to presentations that discuss ways to improve student learning and general wellness in the population.

“While Roseman University’s Research Symposium highlights local research, many of the presenting authors carry affiliations with other great universities such as Jacksonville University, University of Toledo and University of Nebraska, to name a few,” said Dr. Jeffery Talbot, director of Roseman University’s Research Center for Substance Abuse and Depression. “The collaboration between national and international institutions further emphasizes that working together, we can discover much-needed healthcare solutions.”

Student and resident presenters will have the opportunity to win awards for the top research projects, as judged by a panel of internal and external judges.

The event will feature a keynote presentation Sotagliflozin as an Adjunct to Insulin for Patients with Type 1 Diabetes by Dr. David R. Powell, Senior Vice President over Metabolism Research at Lexicon Pharmaceuticals. At Lexicon Pharmaceuticals, Dr. Powell has used mouse gene knockouts (KOs) to identify drug targets. His group searched for metabolism drug targets within the nearly 5000 knockouts of druggable genes shared by mice and humans. Through this effort, Dr. Powell identified SGLT1 and SGLT2 as superior targets leading to the development of sotagliflozin (LX4211), an orally delivered dual SGLT1/SGLT2 inhibitor that improved glycemic control in clinical trials. His group has also developed LX2761, an SGLT1 inhibitor restricted to the intestine, which is undergoing clinical trials. They also studied Xermelo, an oral tryptophan hydroxylase (TPH) inhibitor that lowers serotonin production and treats carcinoid syndrome diarrhea, and performed preclinical studies for LX1031, a TPH inhibitor that provided significant relief to subjects with diarrhea-predominant irritable bowel syndrome. He has also developed antibodies that lower lipid levels and developed inhibitors of Notum, a Wnt deacetylase, which are bone anabolic agents. His group has also found a number of other key genes that are involved in obesity and diabetes, including polymorphisms that are linked to diabetes risk, as well as genes that influence bone mass in humans.

Visit for event information and schedule.

This event is also made possible by additional sponsors including MedQuest, Nu Skin, doTERRA, Sabinsa and Dr. Phung Matthews.

About Roseman University of Health Sciences

Founded in Henderson, Nevada in 1999, Roseman University of Health Sciences is a non-profit, private institution of higher learning training the next generation of undergraduate and graduate level health care professionals that serve, collaborate and set new standards in their communities and within their professions. With campuses in Henderson, Summerlin and South Jordan, Utah, the University is comprised of the College of Dental Medicine, offering an Advanced Education in Orthodontics and Dentofacial Orthopedics/MBA residency and Doctor of Dental Medicine program; College of Pharmacy, offering a Doctor of Pharmacy and Professional Continuing Education; College of Nursing, offering a Bachelor of Science in Nursing and Accelerated Bachelor of Science in Nursing; and an MBA program. Roseman University of Health Sciences will also offer a Doctor of Medicine through its College of Medicine, once it becomes accredited. More than 5,500 Roseman graduates are caring for patients, conducting research, and engaged in public health and policy in Nevada, Utah and across the country. Roseman University is regionally accredited by the Northwest Commission on Colleges and Universities.


Jason Roth
VP, Communications